Cargando…

High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique

BACKGROUND: Epidemiological data of cephalosporin-resistant Enterobacterales in Sub-Saharan Africa is still restricted, and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum β-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical st...

Descripción completa

Detalles Bibliográficos
Autores principales: Estaleva, Calvina E. L., Zimba, Tomas F., Sekyere, John Osei, Govinden, Usha, Chenia, Hafizah Y., Simonsen, Gunnar S., Haldorsen, Bjørg, Essack, Sabiha Y., Sundsfjord, Arnfinn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789290/
https://www.ncbi.nlm.nih.gov/pubmed/33407206
http://dx.doi.org/10.1186/s12879-020-05696-y
_version_ 1783633208190959616
author Estaleva, Calvina E. L.
Zimba, Tomas F.
Sekyere, John Osei
Govinden, Usha
Chenia, Hafizah Y.
Simonsen, Gunnar S.
Haldorsen, Bjørg
Essack, Sabiha Y.
Sundsfjord, Arnfinn
author_facet Estaleva, Calvina E. L.
Zimba, Tomas F.
Sekyere, John Osei
Govinden, Usha
Chenia, Hafizah Y.
Simonsen, Gunnar S.
Haldorsen, Bjørg
Essack, Sabiha Y.
Sundsfjord, Arnfinn
author_sort Estaleva, Calvina E. L.
collection PubMed
description BACKGROUND: Epidemiological data of cephalosporin-resistant Enterobacterales in Sub-Saharan Africa is still restricted, and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum β-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical strains of Escherichia coli at Maputo Central Hospital (MCH), a 1000-bed reference hospital in Maputo, Mozambique. METHODS: A total of 230 clinical isolates of E. coli from urine (n = 199) and blood cultures (n = 31) were collected at MCH during August–November 2015. Antimicrobial susceptibility testing was performed by the disc diffusion method and interpreted according to EUCAST guidelines. Isolates with reduced susceptibility to 3rd generation cephalosporins were examined further; phenotypically for an ESBL−/AmpC-phenotype by combined disc methods and genetically for ESBL- and pAmpC-encoding genes by PCR and partial amplicon sequencing as well as genetic relatedness by ERIC-PCR. RESULTS: A total of 75 isolates with reduced susceptibility to cefotaxime and/or ceftazidime (n = 75) from urine (n = 58/199; 29%) and blood (n = 17/31; 55%) were detected. All 75 isolates were phenotypically ESBL-positive and 25/75 (33%) of those also expressed an AmpC-phenotype. ESBL-PCR and amplicon sequencing revealed a majority of bla(CTX-M) (n = 58/75; 77%) dominated by bla(CTX-M-15). All AmpC-phenotype positive isolates (n = 25/75; 33%) scored positive for one or more pAmpC-genes dominated by bla(MOX/FOX). Multidrug resistance (resistance ≥ three antibiotic classes) was observed in all the 75 ESBL-positive isolates dominated by resistance to trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin. ERIC-PCR revealed genetic diversity among strains with minor clusters indicating intra-hospital spread. CONCLUSION: We have observed a high prevalence of MDR pAmpC- and/or ESBL-producing clinical E. coli isolates with FOX/MOX and CTX-Ms as the major β-lactamase types, respectively. ERIC-PCR analyses revealed genetic diversity and some clusters indicating within-hospital spread. The overall findings strongly support the urgent need for accurate and rapid diagnostic services to guide antibiotic treatment and improved infection control measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05696-y.
format Online
Article
Text
id pubmed-7789290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77892902021-01-07 High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique Estaleva, Calvina E. L. Zimba, Tomas F. Sekyere, John Osei Govinden, Usha Chenia, Hafizah Y. Simonsen, Gunnar S. Haldorsen, Bjørg Essack, Sabiha Y. Sundsfjord, Arnfinn BMC Infect Dis Research Article BACKGROUND: Epidemiological data of cephalosporin-resistant Enterobacterales in Sub-Saharan Africa is still restricted, and in particular in Mozambique. The aim of this study was to detect and characterize extended-spectrum β-lactamase (ESBL) - and plasmid-mediated AmpC (pAmpC)-producing clinical strains of Escherichia coli at Maputo Central Hospital (MCH), a 1000-bed reference hospital in Maputo, Mozambique. METHODS: A total of 230 clinical isolates of E. coli from urine (n = 199) and blood cultures (n = 31) were collected at MCH during August–November 2015. Antimicrobial susceptibility testing was performed by the disc diffusion method and interpreted according to EUCAST guidelines. Isolates with reduced susceptibility to 3rd generation cephalosporins were examined further; phenotypically for an ESBL−/AmpC-phenotype by combined disc methods and genetically for ESBL- and pAmpC-encoding genes by PCR and partial amplicon sequencing as well as genetic relatedness by ERIC-PCR. RESULTS: A total of 75 isolates with reduced susceptibility to cefotaxime and/or ceftazidime (n = 75) from urine (n = 58/199; 29%) and blood (n = 17/31; 55%) were detected. All 75 isolates were phenotypically ESBL-positive and 25/75 (33%) of those also expressed an AmpC-phenotype. ESBL-PCR and amplicon sequencing revealed a majority of bla(CTX-M) (n = 58/75; 77%) dominated by bla(CTX-M-15). All AmpC-phenotype positive isolates (n = 25/75; 33%) scored positive for one or more pAmpC-genes dominated by bla(MOX/FOX). Multidrug resistance (resistance ≥ three antibiotic classes) was observed in all the 75 ESBL-positive isolates dominated by resistance to trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin. ERIC-PCR revealed genetic diversity among strains with minor clusters indicating intra-hospital spread. CONCLUSION: We have observed a high prevalence of MDR pAmpC- and/or ESBL-producing clinical E. coli isolates with FOX/MOX and CTX-Ms as the major β-lactamase types, respectively. ERIC-PCR analyses revealed genetic diversity and some clusters indicating within-hospital spread. The overall findings strongly support the urgent need for accurate and rapid diagnostic services to guide antibiotic treatment and improved infection control measures. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-020-05696-y. BioMed Central 2021-01-06 /pmc/articles/PMC7789290/ /pubmed/33407206 http://dx.doi.org/10.1186/s12879-020-05696-y Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Estaleva, Calvina E. L.
Zimba, Tomas F.
Sekyere, John Osei
Govinden, Usha
Chenia, Hafizah Y.
Simonsen, Gunnar S.
Haldorsen, Bjørg
Essack, Sabiha Y.
Sundsfjord, Arnfinn
High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title_full High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title_fullStr High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title_full_unstemmed High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title_short High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique
title_sort high prevalence of multidrug resistant esbl- and plasmid mediated ampc-producing clinical isolates of escherichia coli at maputo central hospital, mozambique
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789290/
https://www.ncbi.nlm.nih.gov/pubmed/33407206
http://dx.doi.org/10.1186/s12879-020-05696-y
work_keys_str_mv AT estalevacalvinael highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT zimbatomasf highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT sekyerejohnosei highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT govindenusha highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT cheniahafizahy highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT simonsengunnars highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT haldorsenbjørg highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT essacksabihay highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique
AT sundsfjordarnfinn highprevalenceofmultidrugresistantesblandplasmidmediatedampcproducingclinicalisolatesofescherichiacoliatmaputocentralhospitalmozambique